Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC
Condition: Ebola Virus Disease Intervention: Biological: Ad26.ZEBOV, MVA-BN-Filo vaccine Sponsors: London School of Hygiene and Tropical Medicine; Epicentre; Ministère de la Santé de la RDC; Médecins Sans Frontières, France; Coalition for Epidemic Preparedness Innovations; Janssen Vaccines & Prevention B.V.; Public Health England Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials